XML 68 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION
12 Months Ended
Dec. 31, 2013
SEGMENT INFORMATION  
SEGMENT INFORMATION

NOTE 17 SEGMENT INFORMATION

 The Company operates in the packaging components industry, which includes the development, manufacture and sale of consumer product dispensing solutions. The Company is organized into three reporting segments. Operations that sell dispensing solutions primarily to the personal care, beauty and home care markets form the Beauty + Home segment. Operations that sell dispensing solutions to the prescription drug, consumer health care and injectables markets form the Pharma segment. Operations that sell dispensing solutions primarily to the food and beverage markets form the Food + Beverage segment.

        The accounting policies of the segments are the same as those described in Note 1, Summary of Significant Accounting Policies. The Company evaluates performance of its business segments and allocates resources based upon segment income. Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and income taxes.

        Financial information regarding the Company's reportable segments is shown below:

   
 
      
   
   
 
Years Ended December 31,
  2013
  2012
  2011
 

Total Sales:

                   

Beauty + Home

  $ 1,501,611   $ 1,468,599   $ 1,531,479  

Pharma

    709,058     588,853     554,708  

Food + Beverage

    323,469     288,995     269,968  

Corporate & Other

            7  
           

Total Sales

  $ 2,534,138   $ 2,346,447   $ 2,356,162  

Less: Intersegment Sales:

   
 
   
 
   
 
 

Beauty + Home

  $ 13,466   $ 14,659   $ 15,174  

Pharma

    284     160     778  

Food + Beverage

    375     592     3,020  

Corporate & Other

            7  
           

Total Intersegment Sales

  $ 14,125   $ 15,411   $ 18,979  

Net Sales:

   
 
   
 
   
 
 

Beauty + Home

  $ 1,488,145   $ 1,453,940   $ 1,516,305  

Pharma

    708,774     588,693     553,930  

Food + Beverage

    323,094     288,403     266,948  

Corporate & Other

             
           

Net Sales

  $ 2,520,013   $ 2,331,036   $ 2,337,183  

Segment Income (1):

   
 
   
 
   
 
 

Beauty + Home

  $ 109,272   $ 123,527   $ 130,818  

Pharma

    189,689     141,912     164,390  

Food + Beverage

    35,186     30,415     27,801  

Restructuring Initiatives and Related Depreciation

    (14,525 )   (4,678 )   71  

Corporate & Other

    (37,958 )   (33,849 )   (36,560 )
           

Income before interest and taxes

  $ 281,664   $ 257,327   $ 286,520  

Interest expense, net

    (17,281 )   (15,954 )   (11,578 )
           

Income before income taxes

  $ 264,383   $ 241,373   $ 274,942  
               

Depreciation and Amortization (1):

   
 
   
 
   
 
 

Beauty + Home

  $ 83,328   $ 82,828   $ 90,038  

Pharma

    39,812     33,122     28,084  

Food + Beverage

    18,871     15,605     13,413  

Restructuring Initiatives

    2,725     1,576      

Corporate & Other

    5,220     3,891     2,708  
           

Depreciation and Amortization

  $ 149,956   $ 137,022   $ 134,243  

Capital Expenditures:

   
 
   
 
   
 
 

Beauty + Home

  $ 81,247   $ 97,010   $ 101,913  

Pharma

    32,643     24,953     26,911  

Food + Beverage

    19,339     32,282     47,135  

Corporate & Other

    18,281     19,808     3,733  
           

Capital Expenditures

  $ 151,510   $ 174,053   $ 179,692  

Total Assets:

   
 
   
 
   
 
 

Beauty + Home

  $ 1,318,933   $ 1,240,101   $ 1,232,009  

Pharma

    676,420     659,132     404,939  

Food + Beverage

    253,774     233,553     199,170  

Corporate & Other

    248,635     191,626     323,177  
           

Total Assets

  $ 2,497,762   $ 2,324,412   $ 2,159,295  
(1)
The Company evaluates performance of its business units and allocates resources based upon segment income. Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and income taxes. Restructuring Initiatives and related Depreciation includes the following income/(expense) items for the twelve months ended December 31, 2013, 2012 and 2011 as follows:

 
   
   
   
 
Years Ended December 31,
  2013
  2012
  2011
 

European Restructuring Plan

                   

Depreciation

  $ 2,725   $ 1,576   $  

Employee Severance and Other Costs

    11,844     3,314      

Prior Year Initiatives

    (44 )   (212 )   (71 )
               

Total Restructuring Initiatives and Related Depreciation Expense

  $ 14,525   $ 4,678   $ (71 )
               

Restructuring Initiatives and Related Depreciation Expense by Segment

   
 
   
 
   
 
 

Beauty + Home

  $ 14,548   $ 4,787   $ (70 )

Pharma

             

Food + Beverage

    (23 )   (109 )   (1 )
               

Total Restructuring Initiatives and Related Depreciation Expense

  $ 14,525   $ 4,678   $ (71 )
               

GEOGRAPHIC INFORMATION

 The following are net sales and long-lived asset information by geographic area and product information for the years ended December 31, 2013, 2012 and 2011:

   
 
      
   
   
 
 
  2013
  2012
  2011
 

Net Sales to Unaffiliated Customers (1):

                   

United States

  $ 634,418   $ 650,637   $ 636,060  

Europe:

                   

France

    810,528     650,226     630,172  

Germany

    339,858     311,205     308,847  

Italy

    136,617     144,163     168,885  

Other Europe

    165,038     163,695     232,132  
           

Total Europe

    1,452,041     1,269,289     1,340,036  

Other Foreign Countries

    433,554     411,110     361,087  
           

Total

  $ 2,520,013   $ 2,331,036   $ 2,337,183  
               

Plant, Property & Equipment:

   
 
   
 
   
 
 

United States

  $ 226,917   $ 191,697   $ 174,029  

Europe:

                   

France

    263,913     251,015     199,975  

Germany

    156,970     137,203     136,136  

Italy

    57,729     65,743     68,684  

Other Europe

    72,297     72,404     64,921  
           

Total Europe

    550,909     526,365     469,716  

Other Foreign Countries

    86,836     130,171     110,970  
           

Total

  $ 864,662   $ 848,233   $ 754,715  
               

Product Net Sales Information:

   
 
   
 
   
 
 

Pumps

  $ 1,093,514   $ 1,044,226   $ 1,114,276  

Closures

    594,135     605,493     615,243  

Valves

    327,635     327,251     316,900  

Injectables (2)

    142,116     56,465      

Other

    362,613     297,601     290,764  
           

Total

  $ 2,520,013   $ 2,331,036   $ 2,337,183  
               
(1)
Sales are attributed to countries based upon where the sales invoice to unaffiliated customers is generated.
(2)
Injectables represent six month sales in 2012 from the date of acquisition.

No single customer represents 10% or more of the Company's net sales in 2013, 2012 or 2011.